Weight Loss Plateaus Are Normal and Seen in Every Major GLP-1/GIP Study The Standard Weight-Loss Curve Clinical trials consistently show that weight loss with GLP-1 and GLP-1/GIP medications follows a predictable pattern: Rapid weight loss early Gradual slowing over time A plateau phase where weight stabilizes This pattern has been observed across: Semaglutide trials ( STEP program ) Tirzepatide trials ( SURMOUNT-1 , SURMOUNT-4 ) Long-term cardiovascular outcomes studies ( SELECT ) In these studies, most participants lost weight more rapidly during the first several months, then experienced a gradual slowing and reached their average maximum weight loss around 918 months , after which weight tended to stabilize rather than continue to drop indefinitely
That can lead to weight loss and better health
Lifestyle Adjustments for Success Lifestyle adjustments, including dietary changes and increased physical activity, are crucial for successful weight loss with semaglutide
Dose timing and alcohol The question of drinking alcohol on tirzepatide relates to timing in two ways
With adequate protein intake and resistance training, muscle loss can be minimized and functional strength preserved. At Potere Health MD , our physician-supervised medical weight-loss programs are designed to reduce fat while actively preserving muscle through evidence-based nutrition and strength guidance